What Takeda H1B Employees Should Do After the Layoffs

USCIS gives H1B workers a one-time grace period of up to 60 consecutive calendar days (or until your I-94 expires, whichever is shorter) after the end of authorized employment. For Takeda employees, the clock starts on your last day of employment as listed on the I-140/I-129 record and your final paystub — not your notification date, and usually not your last day in the office.

A few critical points most people get wrong:

• **Severance pay does not extend your H1B status.** Takeda's severance package may run for several months, but USCIS treats your employment as ended on your termination date. If your last day on payroll-of-record is June 30, your 60 days run roughly through August 29.
• **The grace period is per authorized validity period, not per layoff.** If you already used it during a prior gap, you may not get another one before your current I-94 expires.
• **You must take an affirmative action within the 60 days** — file a change of status, file an H1B transfer (technically an H1B amendment/extension with a new employer), depart the U.S., or move to a dependent status. Doing nothing means you start accruing unlawful presence on day 61.
• **PERM and I-140 portability still matter.** If Takeda already filed an I-140 for you and it was approved more than 180 days ago, your priority date is portable to a new employer — keep a copy of the I-140 approval notice (I-797) before your corporate email is cut off.

Treat this as a five-day sprint. Order matters.

Day 1-2: Lock down your paper trail. Download from Workday or HR: your full offer letter, every promotion/pay-change letter, all I-797 approval notices (H1B, I-140), your PERM ETA-9089 if you have one, your most recent three years of W-2s, and your last two paystubs. Email them to a personal address. Once IT deactivates your account, getting these back is painful.

Day 3: Pin down your exact termination date in writing. Ask Takeda HR for written confirmation of: (a) last day worked, (b) last day on payroll, (c) whether PTO payout extends the employment end date in their immigration vendor's reporting. Fragomen or whichever firm Takeda uses will report a specific end date to USCIS — you need to know that date.

Day 4: Open conversations with 3-5 employers that sponsor. Don't wait for the perfect job. In pharma/biotech, reliable H1B sponsors include large pharma (Pfizer, Merck, Lilly, BMS, J&J, Novartis, Sanofi, AstraZeneca, GSK, Regeneron, Vertex, Moderna), specialty CROs (IQVIA, ICON, Parexel, Labcorp), and increasingly mid-size biotechs in Boston, San Diego, and the Bay Area. Submit applications with 'currently authorized to work in the U.S. on H1B; require future sponsorship' so recruiters don't filter you out.

Day 5: Talk to an immigration attorney — not just Takeda's. Takeda's firm represents Takeda, not you. A 30-minute paid consult with an independent attorney ($200-400) is worth it to map options against your specific I-140 status, country of birth, and family situation.

Once the immediate paperwork is secured, the next 30 days are about converting the grace period into either a transfer or a status change.

Run two tracks in parallel. Track A is finding a new H1B sponsor. Track B is a backup status change — usually B-2 visitor (gives you up to 6 more months to job hunt but you cannot work), F-1 (if you're returning to school), or H-4 if your spouse holds an H1B or has an approved I-140.

File the H1B transfer the moment you have an offer. The new employer's petition only needs to be received by USCIS before day 60 — not approved. Premium processing ($2,805) gets a decision in 15 business days and is almost always worth it in a layoff scenario. You can start working for the new employer the day the receipt notice is issued, under H1B portability (AC21 §105).

If you have an approved I-140 from Takeda, do not let it get withdrawn out of spite. Companies sometimes withdraw I-140s after termination, but if your I-140 has been approved for 180+ days, the priority date and the ability to extend H1B beyond the 6-year cap survive withdrawal. Save the approval notice now.

Consider a strategic move to a cap-exempt employer. Academic medical centers (Dana-Farber, Mass General Brigham, Memorial Sloan Kettering, MD Anderson), university research labs, and certain nonprofit research institutes are H1B cap-exempt — they can file a petition any time of year with no lottery. Pay is lower but the visa security is real, and you can transition back to a cap-subject employer later if you've already been counted against the cap.

Most laid-off Takeda employees fall into one of these buckets. Match yours honestly.

1. H1B transfer to another pharma/biotech. The default and usually the best option. Your skills are directly transferable to dozens of sponsors. Boston/Cambridge alone has 50+ active pharma H1B filers.

2. O-1A 'extraordinary ability'. Realistic if you have a PhD plus publications, patents, conference talks, peer review history, or press coverage. Many Takeda principal scientists, biostatisticians, and clinical pharmacologists qualify but never realize it. O-1 has no lottery, can be filed by an employer or agent, and is renewable indefinitely.

3. EB-1A or EB-2 NIW self-petition. If you have a strong research record, you can file your own green card petition without an employer. NIW (National Interest Waiver) is the more accessible of the two for pharma scientists working on public health-relevant therapies. You can file while in H1B status with a different employer.

4. L-1 via an international transfer. If Takeda Japan or another global subsidiary will take you for a year, you can later return on an L-1A or L-1B. Slow but viable if H1B options dry up.

5. Cap-exempt academic appointment. As noted above, an instructor or research scientist role at an academic medical center keeps you in H1B status indefinitely.

6. Spousal options. If your spouse holds an H1B with an approved I-140, you can move to H-4 and apply for H-4 EAD — full work authorization, no employer needed.

If you are from India or China and Takeda already filed your PERM, the most important asset is the priority date. Protect it.

These are the patterns immigration attorneys see over and over after pharma layoffs:

• **Treating severance as a runway.** A six-month severance means six months of income, not six months of status. Plan as if your work authorization ends on your last day on payroll.
• **Waiting for the 'right' role.** A mid-level role at a stable sponsor is infinitely better than unlawful presence. You can switch again in 6-12 months under H1B portability.
• **Letting the new employer file in regular processing.** Save up the $2,805 for premium processing. The certainty is worth it.
• **Not getting the I-140 approval notice before losing email access.** USCIS will not re-issue it to you directly; you have to FOIA it, which takes months.
• **Leaving the U.S. during the grace period without a plan.** Once you depart, you generally cannot use the grace period anymore, and you'll need a new H1B visa stamp to return. If your visa stamp has expired, you're stuck abroad waiting for a consulate appointment.
• **Forgetting dependents.** H-4 spouses and children's status is tied to yours. Their 60 days run on the same clock.
• **Ignoring state unemployment.** Most states allow H1B holders to claim unemployment insurance based on Takeda wages. It does not affect your immigration status — accept the benefits you've paid into.

The pharma industry has some quirks that work in your favor compared to a tech layoff.

Hiring is geographically concentrated. Cambridge/Boston, South San Francisco, San Diego, Research Triangle, and central New Jersey absorb the majority of laid-off pharma talent. Relocating within these clusters is often unnecessary.

CROs and consultancies are hungry. IQVIA, Syneos, ICON, Parexel, and ZS Associates routinely hire ex-Takeda regulatory, clinical operations, biostatistics, and commercial analytics people, and they sponsor H1Bs reliably.

Therapeutic area experience is currency. Takeda's oncology, rare disease, plasma-derived therapies, GI, and neuroscience teams have direct counterparts at competitors. Lead your resume with the therapeutic area and the molecule, not just the job title.

Don't undersell GMP/regulatory experience. Manufacturing science, CMC, and regulatory affairs roles have fewer applicants than R&D and often offer faster H1B transfers because the talent pool is smaller.

Watch the academic-industry door. Several Takeda alumni transition to faculty research positions at Harvard, MIT, Tufts, and BU — cap-exempt H1B, slower pace, often a stepping stone back to industry.